BIO5 Latest News

  • Sneeze, sneeze. Cough, cough.  If you don’t have allergies or asthma, someone in your house probably does.  Ever wonder what causes these symptoms?

    Fernando D. Martinez, MD, interim director of the BIO5 Institute at The University of Arizona in Tucson, can tell you. An internationally noted asthma researcher, Dr. Martinez will deliver a presentation titled, Genes and Environment at the Onset of Asthma and Allergies from noon - 1:30 p.m. on Tues., June 30 in the Kiewit Auditorium at the Arizona Cancer Center, 1501 N. Campbell Ave. in Tucson. The lecture is the latest installment of the Buffmire Lecture, sponsored by the Flinn Foundation.

  • UA’s BIO5 Institute is hosting the 13th Annual International Conference on Research in Computational Molecular Biology (RECOMB) May 17-21. The conference has attracted to Tucson, 250 top academic and industry computational biologists from 18 countries for the five-day event. Thirteen faculty, staff and students from the UA are participating, including Ecology and Evolutionary Biology professor Michael Hammer, who is one of seven conference keynote speakers. His UA affiliations include BIO5, Arizona Research Laboratories, Department of Anthropology, and the Arizona Cancer Center.

    To learn more, read Alan Fischer’s story in the Tucson Citizen: http://www.tucsoncitizen.com/daily/breakingnews/116563.php

  • 7 Tucson-based companies and W.L. Gore from Flagstaff confirmed participants

    Arizona bioscience company scientists and human resource representatives will join UA life science, engineering and business students in the first BIO5-hosted bioindustry/student networking event Tues., April 14 from 4-5:30 pm at BIO5’s Thomas W. Keating Bioresearch Building, 1657 E. Helen St. in Tucson. Event sponsors include the BIO5 Institute at The University of Arizona (UA) and Bioindustry Organization of Southern Arizona, the regional affiliate of the Arizona BioIndustry Association (AZBio).

  • New University of Arizona spinoff company Luceome Biotechnologies will make a new technology - called Kinase Seeker - available to academic labs and drug companies worldwide. The technology could speed the development of drugs to treat cancers and other diseases.

    The company is owned and run by BIO5 member Indraneel Ghosh—who is the Weed Endowed Chair and Associate Professor of Chemistry and Biochemistry in the UA College of Science—and by former ImaRx Therapeutics Operations Vice President Dr. Reena Zutshi, who will serve as Luceome's chief executive officer. Ghosh will initially serve as chief scientific officer and then transition into an advisory role.

Syndicate content